Mutations as Predictive Biomarkers for Adenocarcinoma
Fig. 11.1 Molecular landscape of lung adenocarcinoma. Estimation of mutation prevalence is based on targeted next generation sequencing of lung adenocarcinomas performed at Brigham and Women’s Hospital and Dana–Farber Cancer…